Dr. Tiago Reis Marques - 21 Oct 2022 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role
Chief Executive Officer, Director
Signature
/s/ Dr. Tiago Reis Marques
Issuer symbol
KTTA
Transactions as of
21 Oct 2022
Net transactions value
+$5,356
Form type
4
Filing time
21 Oct 2022, 17:05:27 UTC
Previous filing
23 Jun 2022
Next filing
28 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KTTA Common Stock Award $648 +600 +0.07% $1.08 805,600 21 Oct 2022 Direct
transaction KTTA Common Stock Award $4,708 +4,400 +0.55% $1.07 810,000 21 Oct 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.